|115.99||-3.28 / -2.75%|
As of 4:00pm ET
|115.99||0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 131.00, with a high estimate of 163.00 and a low estimate of 110.00. The median estimate represents a +12.94% increase from the last price of 115.99.
The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.